Muhammad Adnan (2024) “RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE STUDIES OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) AND DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS EMPAGLIFLOZIN AND LINAGLIPTIN IN PHARMACEUTICAL DOSAGE FORM”., Journal of Population Therapeutics and Clinical Pharmacology, 31(5), pp. 1697–1709. doi:10.53555/jptcp.v31i5.6335.